Latest News

Yesterday
Total wash elimination for solid phase peptide synthesis Nature.com10:20 9-Dec-23
In the last 7 days
Novo Nordisk Must Face Bulk Of Woman's Ozempic Injury Suit Law36017:03 8-Dec-23
Validea Detailed Fundamental Analysis - NVO Nasdaq14:22 8-Dec-23
Is Altimmune (ALT) stock a good buy after the 306% jump? Invezz10:49 8-Dec-23
Novo, Lilly rivals explore booming weight-loss drug market entry Reuters10:11 8-Dec-23
Pfizer's Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy? The Motley Fool09:35 8-Dec-23
How weight-loss drugs could upend the consumer economy Tortoise06:04 8-Dec-23
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market? The Motley Fool05:41 8-Dec-23
Obesity Drug Stocks: Where to Invest Now MorningStar.com17:19 7-Dec-23
A Danish court orders a British financier to remain in pre-trial custody on tax fraud Yahoo! UK & Ireland09:41 7-Dec-23
Thinking about trading options or stock in Novo Nordisk, Vale, Cerevel Therapeutics, Braze Inc, … PR Newswire (Press Release)09:31 7-Dec-23
Inside Novo Nordisk, the Danish Drugmaker Behind Ozempic The Wall Street Journal18:40 6-Dec-23
Novo Nordisk showers at least $25.8M on U.S. obesity doctors, Reuters says HealthLeaders12:15 6-Dec-23
Novo’s Wegovy Has Highest Adherence Rates in New Study of Weight-Loss Drugs BioSpace10:55 6-Dec-23
STAT Plus: A bold approach to pay for weight loss drugs for everyone who needs them STAT04:41 6-Dec-23
Adherence to Wegovy at 40% a year later, but still much higher than for older drugs Financial Mail04:31 6-Dec-23
Adherence to weight-loss drugs is far higher with Wegovy than older medicines Reuters03:14 6-Dec-23
Can Wegovy Fight Alcoholism? For Big Pharma, This Isn’t a Priority BNN Bloomberg00:27 6-Dec-23
Liraglutide by Novo Nordisk for Pouchitis: Likelihood of Approval Pharmaceutical Technology21:17 5-Dec-23
AstraZeneca and Novo Nordisk among the top picks of this top US bank - here's why Proactive Investors (US)11:15 5-Dec-23
Novo Nordisk: From diabetes to weight loss to obesity preventions Proactive Investors (UK)09:26 5-Dec-23
Eli Lilly’s New Weight-Loss Drug Now on Sale to Rival Hard-to-Find Wegovy BNN Bloomberg09:12 5-Dec-23
Eli Lilly and Company’s GLP-1 Weight Loss Drug Is Now Available in the US for as Low as $25 Wccftech09:09 5-Dec-23
Novo Nordisk Pharma Thailand Celebrates Fourth Consecutive Year as 'Best Place to Work and back-to-back for Best Place… MediaOutReach (Press Release)06:46 5-Dec-23
Novo Nordisk ascent: Will Europe’s biggest company continue to soar? euronews05:18 5-Dec-23
NN-6581 by Novo Nordisk for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood … Pharmaceutical Technology00:43 5-Dec-23
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners'… Benzinga20:46 4-Dec-23
Roche Elbows into Weight-Loss Drug Market Via M&A Power Corridor18:40 4-Dec-23
Ozempic maker sued by Iowa woman over alleged side effects Iowa Capital Dispatch17:19 4-Dec-23
Roche Will Buy Obesity And Diabetes Drugmaker Carmot Therapeutics In $2.7 Billion Deal Forbes14:31 4-Dec-23
Weight-Loss Boom Gets a New Player as Roche Buys Biotech With Hunger Drug in Its Pipeline The Messenger11:35 4-Dec-23
Roche joins the pharma gold rush after buying an obesity drug for $3bn Irish Examiner09:47 4-Dec-23
Roche enters obesity market with Carmot takeover but drugs may not be available until 2030 CNBC09:46 4-Dec-23
STAT Plus: Pharmalittle: Roche to buy obesity-drug developer for $2.7 billion; Novo Nordisk… STAT09:19 4-Dec-23
Roche takes on weight-loss drug firms Financial Mail09:17 4-Dec-23
Roche joins obesity drug chase with $2.7B deal for startup Carmot BioPharma Dive09:03 4-Dec-23
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs Benzinga08:23 4-Dec-23
Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It Hopes to Compete with Eli Lilly, Novo Nordisk. Barron's Online07:53 4-Dec-23
Roche weighs in on obesity drug market with $2.7bn Carmot buy BioProcess Insider07:46 4-Dec-23
Novo Nordisk A/S - share repurchase programme GlobeNewswire (Press Release)07:46 4-Dec-23
Roche acquires obesity drug developer Carmot Therapeutics for $3.1bn NewsBytes05:47 4-Dec-23
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s… MarketWatch05:44 4-Dec-23
Roche enters obesity drug market with Carmot deal RTE03:29 4-Dec-23
Roche to acquire Carmot Therapeutics for $2.7 bln Reuters01:20 4-Dec-23
US: Chasing Weight Loss Dream, Many in America Seek So-Called 'Wonder Drugs' News18.com22:14 3-Dec-23
3 No-Brainer Growth Stocks to Buy in December The Motley Fool07:00 3-Dec-23
In the last month
Novo Nordisk to expand GLP-1 production in France Chemical & Engineering News19:44 2-Dec-23
Everyone Is Talking About This Stock. Is It a Good Long-Term Option? Nasdaq09:46 2-Dec-23
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk? The Motley Fool06:03 2-Dec-23
Crucial plans mapped out to decarbonise healthcare and manufacturing in China, India, UAE edie.net05:00 2-Dec-23
Illegal 'weight loss pens' are being given away for free on social media: Alert over fake… Mail Online03:31 2-Dec-23
Novo Nordisk pays $25.8 million to promote its obesity drug Livemint.com20:43 1-Dec-23
Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal… Fortune19:48 1-Dec-23
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs NTD News17:42 1-Dec-23
Pfizer’s Mixed Readout Places Doubt On Oral GLP-1 For Obesity Scrip Pharma Intelligence17:04 1-Dec-23
Advocacy for Wegovy: Denmark Signals Cost-Sharing Talks While Novo Spent Millions On Medical Community For Drug… Benzinga15:47 1-Dec-23
Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly CNBC13:31 1-Dec-23
Signal: Novo Nordisk sues more Florida pharmacies in battle against fake semaglutide Pharmaceutical Technology12:17 1-Dec-23
Novo Nordisk takes legal action over copycat Ozempic medication The Hill12:13 1-Dec-23
Denmark could help more patients with Wegovy cost if Novo pays too -minister Reuters11:17 1-Dec-23
Novo Nordisk to Make Multi-Billion Dollar Investment in Expansion of Production Facilities in France PharmTech.com10:46 1-Dec-23
Patent Owners file Amicus Brief in Support of Cellect’s Rehearing Petition JD Supra10:32 1-Dec-23
Suicide Risk From Weight-Loss Drugs Prompts More EU Questions BNN Bloomberg10:28 1-Dec-23
Novo Nordisk outsized growth 'likely to continue to exceed Street expectations' - Cantor… Investing.com10:19 1-Dec-23
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy Reuters08:34 1-Dec-23
Will Novo Nordisk Be a Trillion-Dollar Stock by 2030? The Motley Fool08:30 1-Dec-23
Eli Lilly, Novo Nordisk to benefit as Pfizer’s weight loss drug implodes Invezz08:08 1-Dec-23
EU watchdog seeks more data from GLP-1 drugmakers on suicidal thoughts Reuters08:03 1-Dec-23
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors Reuters07:02 1-Dec-23
Drug Money Reuters06:01 1-Dec-23
Altimmune Stock (NASDAQ:ALT) Rallies on Positive Obesity Drug Results TipRanks01:41 1-Dec-23
Novo Nordisk takes legal action over copycat weight loss medication The Olympian, Washington20:18 30-Nov-23
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs CNBC17:04 30-Nov-23
Novo Nordisk Claims Ozempic Knockoffs Aren’t Just Cheap — They’re Dangerous Rolling Stone15:29 30-Nov-23
Novo Nordisk ramps up legal case against compounding pharmacies selling 'misbranded' semaglutide ENDPOINTS14:33 30-Nov-23
Novo Nordisk sues two pharmacies for allegedly offering contaminated copycat Ozempic NBC News13:57 30-Nov-23
Compounded Wegovy Matters Sink Novo Nordisk (NYSE:NVO) TipRanks11:47 30-Nov-23
Fighting unauthorized GLP-1 knockoffs, Novo Nordisk files 2 new lawsuits against Florida… FiercePharma11:18 30-Nov-23
Novo Nordisk Sues Two Florida Pharmacies For Allegedly Selling Impure Weight-Loss Drugs Forbes10:03 30-Nov-23
Ozempic Knock-Offs Contain an Unsafe Substance Banned by the FDA BNN Bloomberg09:30 30-Nov-23
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies Reuters06:25 30-Nov-23
Rival drugmakers enter the weight loss race Investors Chronicle05:54 30-Nov-23
Study: Type 2 diabetes medication Mounjaro is better than Ozempic for weight loss theGrio13:17 29-Nov-23
STAT Plus: Saudi VC loops Novo Nordisk, other biotech VCs into new longevity incubator STAT07:09 29-Nov-23
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock? The Motley Fool05:54 29-Nov-23
Pediatric Drugs Market: The Growth Cycle Continues| Bayer, Eli Lilly, Novo Nordisk Industry Today04:28 29-Nov-23
Global Healthcare Leaders Advance Sector Decarbonisation Ahead of COP28 Business Wire (Press Release)02:00 29-Nov-23
Sean Keyes on investing: The market’s forecast for obesity drugs The Currency22:28 28-Nov-23
After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic Financial Mail19:10 28-Nov-23
A Large New Study on Weight Loss Drugs Like Wegovy Has Good News if You’re Looking To Reduce Your Heart Attack Risk The Tribune, California18:56 28-Nov-23
Counterfeit Ozempic Likely Caused 11 Cases Of Hypoglycemia In Lebanon Forbes18:23 28-Nov-23
Novo Nordisk added a fifth new lobbying firm this summer Politico17:13 28-Nov-23
Suspected fake Ozempic causes hypoglycaemia in 11 in Lebanon Middle East Monitor16:13 28-Nov-23
Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon Reuters14:23 28-Nov-23
Popular Weight-Loss Drug Semaglutide Might Help With Alcohol Dependence, Too Gizmodo13:03 28-Nov-23
Eli Lilly (NYSE:LLY) Pops Up After Beating Novo Nordisk (NYSE:NVO) In Weight Loss TipRanks12:11 28-Nov-23
Will GLP-1 Weight Loss Drugs Allow Airlines to Save Millions of Dollars and Tank the Fast Food… Wccftech10:28 28-Nov-23
The Zacks Analyst Blog Highlights Gartner, The Progressive, InterContinental Hotels, Cboe Global Markets and Novo… Zacks04:36 28-Nov-23
Pharma's Q3 growth rankings: GLP-1 drugs from Eli Lilly, Novo Nordisk were once again the big… FiercePharma03:02 28-Nov-23
Novo Nordisk invests €2.1bn in production expansion European Biotechnology News02:42 28-Nov-23
Lilly's Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds Reuters18:53 27-Nov-23
Mounjaro Outperforms Ozempic in Weight Loss Effectiveness, Study Finds Business Times17:34 27-Nov-23
Health Care Slips as Novo Nordisk Gives Back Some Gains -- Health Care Roundup MarketWatch17:07 27-Nov-23
Diabetes drug Mounjaro more effective for weight loss than Ozempic: Analysis Bellingham Herald16:28 27-Nov-23
Novo Nordisk (NYSE:NVO) Falls as Large Investor Offloads Shares TipRanks16:01 27-Nov-23
Local Virginia governments add to insulin lawsuits against Eli Lilly, Novo Nordisk, Sanofi, others ENDPOINTS15:02 27-Nov-23
Mounjaro Beats Ozempic in Real-World Study Barron's Online13:48 27-Nov-23
Mounjaro outperforms Ozempic for weight loss in adults, study says Proactive Investors (US)13:42 27-Nov-23
Sectors Upclose: Novo Nordisk is ‘almost like the Nvidia of Europe’ Reuters - YouTube13:01 27-Nov-23
GLP-1 Drug War: Obese Patients Are Typically Twice as Likely To Lose 15% Or More of Their Body… Wccftech12:25 27-Nov-23
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments Benzinga11:24 27-Nov-23
Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds MarketWatch10:40 27-Nov-23
Thinking about trading options or stock in Shopify, Novo Nordisk, Verve Therapeutics, Cerence,… PR Newswire (Press Release)09:35 27-Nov-23
Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation Seeking Alpha09:31 27-Nov-23
Novo Nordisk keeps GLP-1 expansion spree rolling with $2.3B manufacturing upgrade in France FiercePharma09:15 27-Nov-23

      
            
      
    view more headlines
   
      
      
      
9 Dec 10:20
   

About our Novo Nordisk news

Latest news on Novo Nordisk, a Danish multinational pharmaceutical company that manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. The company is also involved with hemostasis management, growth hormone therapy, and hormone replacement therapy.

Novo Nordisk

Latest News

About our Novo Nordisk news

Pharmaceuticals Top Stories

Business Top Stories